Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

33.22
+1.715.43%
Pre-market: 33.400.1800+0.54%09:15 EDT
Volume:3.23M
Turnover:107.08M
Market Cap:5.30B
PE:11.97
High:33.87
Open:31.95
Low:31.78
Close:31.51
52wk High:46.48
52wk Low:25.28
Shares:159.69M
Float Shares:148.00M
Volume Ratio:1.87
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.78
EPS(LYR):2.77
ROE:102.75%
ROA:9.39%
PB:8.19
PE(LYR):11.99

Loading ...

May 10, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Major Issues Report

8-K - Current report
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 08, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]